TPX-0046

TPX-0046 is a RET inhibitor designed to overcome resistance to Selpercatinib and Pralsetinib.

2359650-19-2

≥ 2 years

>98% (HPLC)

424.43

C21H21FN6O3

Research use only, not for human use.

BCRP|ABCG2

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

CF800283 100 µg

Ask

GA-E0677RT-01 48 Tests

Ask

GA-E0677RT-02 96 Tests

Ask

bs-9520R-Cy3 100 µL

Ask

ANT-12848-100ug 100 µg

Ask

abx535377 96 Tests

Ask